The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

StocksMedium•18 February 2026•

1 min read

Prenetics Reports Record 480% Revenue Surge in FY 2025 Driven by IM8 Brand Growth

A man in a suit over a stock chart with 'Mondelez International' text, surrounded by chocolate, cocoa beans, factories, and shops.

Prenetics Global Limited (NASDAQ: PRE) announced record-breaking financial results for the fourth quarter and full fiscal year ended December 31, 2025. The company reported a massive 480% year-over-year increase in revenue, highlighting a period of exceptional operational expansion. A primary driver of this growth was the IM8 health and longevity brand, which achieved $120 million in Annual Recurring Revenue (ARR) within just 12 months of its launch. These results reflect rapid market adoption and the successful scaling of the company's premium health and wellness offerings. Management's strategic focus on high-growth segments has positioned Prenetics as a significant player in the health sciences sector. Investors are closely monitoring the stock as these figures underscore a strong financial trajectory and robust operational efficiency heading into 2026.